2056-5933

RMD Open

BMJ

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add license metadata to 525 records

License metadata tells indexers and readers how each article may be reused.

Low impact525 DOIs
2

Attach ORCID iDs across 399 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact399 DOIs
3

Add abstracts to 210 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact210 DOIs

DOIs for this ISSN

Showing the top 5 of 2101 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Active discopathy: a clinical reality (10.1136/rmdopen-2018-000660)
Abstract References ORCID License
146.24 28
2 Impact of intensive treatment and remission on health-relate… (10.1136/rmdopen-2016-000270)
Abstract References ORCID License
138.02 23
3 Scoring ultrasound synovitis in rheumatoid arthritis: a EULA… (10.1136/rmdopen-2016-000428)
ORCID License
128.11 364
4 Safety and efficacy of baricitinib in elderly patients with… (10.1136/rmdopen-2017-000546)
Abstract ORCID License
128.07 50
5 EULAR Sjögren's syndrome disease activity index (ESSDAI): a… (10.1136/rmdopen-2014-000022)
ORCID License
127.20 349
6 Association between diabetes mellitus and osteoarthritis: sy… (10.1136/rmdopen-2015-000077)
ORCID License
124.29 305
7 Imaging in diagnosis, outcome prediction and monitoring of l… (10.1136/rmdopen-2017-000612)
ORCID License
121.33 266
8 Glucocorticoid-induced osteoporosis (10.1136/rmdopen-2014-000014)
ORCID License
119.55 245
9 Post-traumatic arthritis: overview on pathogenic mechanisms… (10.1136/rmdopen-2016-000279)
ORCID License
116.42 212
10 Paradoxical reactions under TNF-α blocking agents and other… (10.1136/rmdopen-2015-000239)
ORCID License
113.12 182
11 Rheumatic immune-related adverse events of checkpoint therap… (10.1136/rmdopen-2016-000412)
ORCID License
112.52 177
12 Increased B-cell activating factor (BAFF)/B-lymphocyte stimu… (10.1136/rmdopen-2018-000693)
Abstract ORCID License
110.78 29
13 Systemic lupus erythematosus and fractures (10.1136/rmdopen-2015-000069)
Abstract References License
109.68 28
14 Th1 is the predominant helper T cell subset that produces GM… (10.1136/rmdopen-2017-000487)
Abstract ORCID License
109.68 28
15 Effects of exercise and physical activity promotion: meta-an… (10.1136/rmdopen-2018-000713)
ORCID License
105.70 129
16 Rheumatoid arthritis treatment: the earlier the better to pr… (10.1136/rmdopen-2015-000057)
ORCID License
105.02 125
17 Early knee osteoarthritis (10.1136/rmdopen-2015-000062)
ORCID License
104.67 123
18 Synovial tissue macrophages: friend or foe? (10.1136/rmdopen-2017-000527)
ORCID License
103.96 119
19 Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-depe… (10.1136/rmdopen-2015-000061)
ORCID License
103.03 114
20 Autoinflammatory granulomatous diseases: from Blau syndrome… (10.1136/rmdopen-2015-000097)
ORCID License
102.46 111
21 Synovial fibroblasts in 2017 (10.1136/rmdopen-2017-000471)
ORCID License
101.67 107
22 Patient-reported outcomes as end points in clinical trials i… (10.1136/rmdopen-2014-000019)
ORCID License
101.47 106
23 Real-life assessment of the validity of patient global impre… (10.1136/rmdopen-2015-000146)
ORCID License
101.06 104
24 Lifestyle factors may modify the effect of disease activity… (10.1136/rmdopen-2015-000153)
ORCID License
100.00 99
25 Epidemiology of neurological manifestations in Sjögren's syn… (10.1136/rmdopen-2015-000179)
ORCID License
100.00 99
26 Stroke in systemic lupus erythematosus: a meta-analysis of p… (10.1136/rmdopen-2015-000168)
ORCID License
99.78 98
27 DAS28-CRP and DAS28-ESR cut-offs for high disease activity i… (10.1136/rmdopen-2016-000382)
ORCID License
99.78 98
28 Predictors of response to TNF antagonists in patients with a… (10.1136/rmdopen-2014-000017)
ORCID License
98.89 94
29 Non-radiographic axial spondyloarthritis and ankylosing spon… (10.1136/rmdopen-2015-000053)
ORCID License
98.66 93
30 Era of biosimilars in rheumatology: reshaping the healthcare… (10.1136/rmdopen-2019-000900)
ORCID License
98.42 92
31 Novel heterozygous C243Y A20/TNFAIP3 gene mutation is respon… (10.1136/rmdopen-2015-000223)
ORCID License
97.71 89
32 Salivary gland ultrasound abnormalities in primary Sjögren’s… (10.1136/rmdopen-2016-000364)
ORCID License
97.71 89
33 Treatment of systemic sclerosis: is there any hope for the f… (10.1136/rmdopen-2016-000260)
Abstract ORCID License
95.91 18
34 What makes psoriatic and rheumatoid arthritis so different? (10.1136/rmdopen-2014-000025)
ORCID License
95.15 79
35 The osteocyte: key player in regulating bone turnover (10.1136/rmdopen-2015-000049)
ORCID License
95.15 79
36 Association between osteoarthritis and dyslipidaemia: a syst… (10.1136/rmdopen-2017-000442)
ORCID License
95.15 79
37 MR signal intensity: staying on the bright side in MR image… (10.1136/rmdopen-2018-000728)
ORCID License
95.15 79
38 Fatigue in primary Sjögren's syndrome is associated with low… (10.1136/rmdopen-2016-000282)
ORCID License
94.88 78
39 Obesity and inflammatory arthritis: impact on occurrence, di… (10.1136/rmdopen-2014-000012)
ORCID License
94.60 77
40 Characteristics and treatment of new-onset arthritis after c… (10.1136/rmdopen-2018-000714)
ORCID License
94.32 76
41 Detection of antibodies to citrullinated tenascin-C in patie… (10.1136/rmdopen-2016-000318)
Abstract ORCID License
94.15 17
42 Switching from originator biological agents to biosimilars:… (10.1136/rmdopen-2017-000492)
Abstract ORCID License
94.15 17
43 Tophus resolution with pegloticase: a prospective dual-energ… (10.1136/rmdopen-2015-000075)
ORCID License
94.04 75
44 Update on interleukin-17: a role in the pathogenesis of infl… (10.1136/rmdopen-2016-000284)
ORCID License
94.04 75
45 Distinct interferon signatures stratify inflammatory and dys… (10.1136/rmdopen-2018-000811)
ORCID License
94.04 75
46 Long-term efficacy and safety of secukinumab 150 mg in ankyl… (10.1136/rmdopen-2019-001005)
ORCID License
94.04 75
47 Comparative effectiveness of biologic monotherapy versus com… (10.1136/rmdopen-2015-000181)
ORCID License
93.46 73
48 Characteristics of rheumatoid arthritis and its association… (10.1136/rmdopen-2016-000267)
ORCID License
93.46 73
49 Real-world burden of comorbidities in US patients with psori… (10.1136/rmdopen-2017-000588)
ORCID License
93.46 73
50 Expert consensus on dynamics of laboratory tests for diagnos… (10.1136/rmdopen-2015-000161)
ORCID License
93.17 72